b'Scientific Session Abstracts SATURDAY APRIL 20, 2024 Not done 1,209 (92.7%) 170 (90.4%) 295 (81.5%)CardiacNormal 84 (6.4%) 16 (8.5%) 64 (17.7%) 0.001Stress TestAbnormal 11 (0.8%) 2 (1.1%) 3 (0.8%)Full 987 (75.7%) 135 (71.8%) 245 (67.7%)PreoperativeLight work 181 (13.9%) 29 (15.4%) 68 (18.8%)FunctionalSelf-care 112 (8.6%) 20 (10.6%) 39 (10.8%) 0.115StatusAssisted care or24 (1.8%) 4 (2.1%) 10 (2.8%)bedbound30% 10 (0.8%) 4 (2.1%) 5 (1.4%)30-50% 88 (6.8%) 13 (6.9%) 32 (8.8%)EF 0.00150% 750 (57.5%) 138 (73.4%) 254 (70.2%)No EF record 456 (34.9%) 33 (17.6%) 71 (19.6%)Surgical HistoryHistory of aortic aneurysm repair 57 (4.4%) 7 (3.7%) 20 (5.5%) 0.552History of aortic surgery 52 (3.9%) 4 (2.1%) 19 (5.3%) 0.208History of bypass surgery 32 (2.5%) 4 (2.1%) 27 (7.5%) 0.001History of CABG 28 (2.2%) 5 (2.7%) 10 (2.8%) 0.748History of CEA or CAS 7 (0.5%) 0 1 (0.3%) 0.508History of PCI 70 (5.4%) 8 (4.3%) 21 (5.8%) 0.744History of PVI 21 (1.6%) 2 (1.1%) 10 (2.8%) 0.251Medication HistoryACE inhibitors 486 (37.3%) 81 (43.1%) 192 (53.0%) 0.001Anticoagulants 128 (9.8%) 14 (7.5%) 35 (9.7%) 0.584Aspirin 461 (35.4%) 81 (43.1%) 178 (49.2%) 0.001Beta blockers 951 (72.9%) 156 (82.9%) 309 (85.4%) 0.001P2Y12 inhibitors 49 (3.8%) 6 (3.2%) 11 (3.0%) 0.775Statins 493 (37.8%) 77 (40.9%) 203 (56.1%) 0.00142 NDANNUAL MEETING|APRIL 1921, 2024|OCEANSIDE, CA 53'